Susan Palmer1, Pandora Patterson2, Kate Thompson3. 1. AYA Psychologist,Melbourne, Victoria,Australia. 2. CanTeen Australia, Sydney, New South Wales,Australia. 3. ONTrac at Peter Mac, Victorian Adolescent & Young Adult Cancer Service,Peter MacCallum Cancer, Melbourne, Victoria,Australia.
Abstract
OBJECTIVE: Age-based screening tools and assessment measures are crucial to the provision of best practice care for adolescent and young adult (AYA) cancer patients. Unfortunately, there are limited psychosocial tools developed for this age group and pediatric or adult measures are often distributed with the assumption that they are "close enough." We describe a collaborative Australian project that strives to improve what currently exists for the psychosocial assessment of and planning for the 15-25-year-old age group. METHOD: Using the National Comprehensive Cancer Network's Distress Thermometer and the HEADSS Assessment as a foundation, the tools were developed in consultation with Australia's leading AYA clinicians, AYAs currently undergoing medical treatment, and a group of AYA survivors through a process of discussion groups and clinical interviews. RESULTS: The result is the first available AYA-specific screening tool, care plan pro forma, and psychosocial assessment measure developed for use within the oncology sector. These new tools will assist clinicians working with this population group to support psychosocial coping during active treatment and promote healthy post-treatment survivorship. SIGNIFICANCE OF RESULTS: Over time, further validation procedures will add to the veracity of the measures. Until then, these measures represent the best available in Australia. They highlight a clinically recognized minimum standard of care that all young cancer patients, regardless of treatment location, have the right to receive.
OBJECTIVE: Age-based screening tools and assessment measures are crucial to the provision of best practice care for adolescent and young adult (AYA) cancerpatients. Unfortunately, there are limited psychosocial tools developed for this age group and pediatric or adult measures are often distributed with the assumption that they are "close enough." We describe a collaborative Australian project that strives to improve what currently exists for the psychosocial assessment of and planning for the 15-25-year-old age group. METHOD: Using the National Comprehensive Cancer Network's Distress Thermometer and the HEADSS Assessment as a foundation, the tools were developed in consultation with Australia's leading AYA clinicians, AYAs currently undergoing medical treatment, and a group of AYA survivors through a process of discussion groups and clinical interviews. RESULTS: The result is the first available AYA-specific screening tool, care plan pro forma, and psychosocial assessment measure developed for use within the oncology sector. These new tools will assist clinicians working with this population group to support psychosocial coping during active treatment and promote healthy post-treatment survivorship. SIGNIFICANCE OF RESULTS: Over time, further validation procedures will add to the veracity of the measures. Until then, these measures represent the best available in Australia. They highlight a clinically recognized minimum standard of care that all young cancerpatients, regardless of treatment location, have the right to receive.
Authors: Lauri A Linder; Jeanne M Erickson; Kristin Stegenga; Catherine Fiona Macpherson; Sarah Wawrzynski; Christina Wilson; Suzanne Ameringer Journal: Support Care Cancer Date: 2017-07-17 Impact factor: 3.603
Authors: Alex W K Wong; Ting-Ting Chang; Katrina Christopher; Stephen C L Lau; Lynda K Beaupin; Brad Love; Kim L Lipsey; Michael Feuerstein Journal: J Cancer Surviv Date: 2017-03-29 Impact factor: 4.442
Authors: Pandora Patterson; Fiona E J McDonald; Kimberley R Allison; Helen Bibby; Michael Osborn; Karen Matthews; Ursula M Sansom-Daly; Kate Thompson; Meg Plaster; Antoinette Anazodo Journal: Front Psychol Date: 2022-05-06
Authors: Dristhi Ragoonanan; Sajad J Khazal; Hisham Abdel-Azim; David McCall; Branko Cuglievan; Francesco Paolo Tambaro; Ali Haider Ahmad; Courtney M Rowan; Cristina Gutierrez; Keri Schadler; Shulin Li; Matteo Di Nardo; Linda Chi; Alison M Gulbis; Basirat Shoberu; Maria E Mireles; Jennifer McArthur; Neena Kapoor; Jeffrey Miller; Julie C Fitzgerald; Priti Tewari; Demetrios Petropoulos; Jonathan B Gill; Christine N Duncan; Leslie E Lehmann; Sangeeta Hingorani; Joseph R Angelo; Rita D Swinford; Marie E Steiner; Fiorela N Hernandez Tejada; Paul L Martin; Jeffery Auletta; Sung Won Choi; Rajinder Bajwa; Natalie Dailey Garnes; Partow Kebriaei; Katayoun Rezvani; William G Wierda; Sattva S Neelapu; Elizabeth J Shpall; Selim Corbacioglu; Kris M Mahadeo Journal: Nat Rev Clin Oncol Date: 2021-02-19 Impact factor: 65.011
Authors: Jeremy Lewin; Kate Thompson; Susie Bae; Jayesh Desai; Robyn Strong; Denise Caruso; Deborah Howell; Alan Herschtal; Michael Sullivan; Lisa Orme Journal: Sarcoma Date: 2017-02-28
Authors: John Alexander Chalmers; Ursula Margaret Sansom-Daly; Pandora Patterson; Geoffrey McCowage; Antoinette Anazodo Journal: JMIR Res Protoc Date: 2018-08-29
Authors: Viswatej Avutu; Kathleen A Lynch; Marie E Barnett; Jacqueline A Vera; Julia L Glade Bender; William D Tap; Thomas M Atkinson Journal: Cancers (Basel) Date: 2022-01-29 Impact factor: 6.575
Authors: Pandora Patterson; Kimberley R Allison; Helen Bibby; Kate Thompson; Jeremy Lewin; Taia Briggs; Rick Walker; Michael Osborn; Meg Plaster; Allan Hayward; Roslyn Henney; Shannyn George; Dominic Keuskamp; Antoinette Anazodo Journal: Cancers (Basel) Date: 2021-05-28 Impact factor: 6.639